Publications by authors named "G Aliberti"

Claim this Profile
R
Radioembolization of hepatocellular carcinoma with Y glass microspheres: an earlier administration day unexpectedly improves tumour control probability.
Matteo Bagnalasta, Stefania Mazzaglia, Maria Chiara De Nile, Chiara Romanò, Giovanna Pitoni, Gianluca Aliberti

Eur J Nucl Med Mol Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro‑entero‑pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu] Lu‑DOTATATE.
Marco Maccauro, Mariarosaria Cuomo, Matteo Bauckneht, Matteo Bagnalasta, Stefania Mazzaglia, Gianluca Aliberti

Eur J Nucl Med Mol Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reported Breast MRI Among U.S. Women Undergoing Screening Mammography: a National Cross-Sectional Study.
Gianna M Aliberti, Emily A Wolfson, Christine M Gunn, Sachin J Shah, Mara A Schonberg

J Gen Intern Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reported Mammography Screening Interval by Age Among U.S. Women: A National Cross-Sectional Study.
Meehir N Dixit, Emily A Wolfson, Gianna M Aliberti, Mara A Schonberg

Ann Intern Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [Lu]Lu-DOTATATE.
Marco Maccauro, Mariarosaria Cuomo, Matteo Bauckneht, Matteo Bagnalasta, Stefania Mazzaglia, Gianluca Aliberti

Eur J Nucl Med Mol Imaging· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis